Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSPE.L Regulatory News (SPE)

  • There is currently no data for SPE

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

New Approach to Product Development with Accolade

29 Jun 2017 07:00

RNS Number : 4020J
Sopheon PLC
29 June 2017
 

 

For immediate release

 

California Olive Ranch Takes a Fresh Approach to Product Development with Sopheon's Accolade Software

 

Deployment Highlights a Desire for Simplicity and Discipline as the Company Navigates a Trajectory of Growth

 

MINNEAPOLIS-June 29, 2017-Sopheon, the international provider of software, expertise, and best practices for Enterprise Innovation Performance, today announces that California Olive Ranch Inc., the largest producer of extra virgin olive oil in the United States, has selected and deployed Sopheon's Accolade® Express software to enhance the management of its new product development (NPD) processes.

 

Founded in 1998, California Olive Ranch has pioneered new ways of cultivating and harvesting olives in order to make extra virgin olive oil premium and affordable. The company has developed its own ranches and has helped family farmers throughout Northern California develop previously unusable farm acreage into olive orchards. Led by a CEO who transitioned from the high-tech world to the farming world, the company leverages time honored farming techniques while fully embracing modern technology.

 

The success of the company in recent years, together with expansion into new markets and food product sectors, has resulted in impressive growth. While a positive step, this has added complexity to once simple to manage product development processes. As the company scales to meet aggressive plans for further growth, California Olive Ranch elected to partner with Sopheon to implement and digitize newly-designed planning and operational execution processes designed to enhance its ability to execute on its growth strategy and further advance its leadership position in the market.

 

"Sopheon is helping us to scale but still keep things simple," said Mary Bolton, Director of Technical Services. "Using the best-practice new product development processes and document templates built into the Accolade Express software, we are collecting the information we need for good, collaborative decision-making and are defining and operationalizing new and more efficient processes across the company. With a small amount of training, we have been able to configure these standard processes and templates to incorporate our language and make them 'ours' without making things complicated."

 

Reflecting on the implementation, Ms. Bolton stated: "We love the ease of use and capabilities of the software. It's giving us discipline, providing visibility into project status and progress through reporting and analytics dashboards, and enabling more efficient decision making across the lifecycle of our development projects. Looking to the future, we are becoming aware of how we could extend the use of Accolade to different types of projects beyond new product development."

Sopheon and Accolade are trademarks of Sopheon plc.

 

For further information contact:

Barry Mence, ChairmanArif Karimjee, CFO

Sopheon plc

+ 44 (0) 1276 919 560

Carl Holmes/Giles Rolls (corporate finance)

Mia Gardener (corporate broking)

finnCap

+ 44 (0) 20 7220 0500

 

 

About Sopheon. Sopheon partners with customers to provide complete Enterprise Innovation Management solutions including patented software, expertise, and best practices to achieve exceptional long-term revenue growth and profitability. Sopheon's Accolade® solution provides unique, fully-integrated coverage for the entire innovation management and new product development lifecycle, including strategic innovation planning, roadmapping, idea and concept development, process and project management, portfolio management and resource planning. Sopheon's solutions have been implemented by over 250 customers with over 60,000 users in over 50 countries. Sopheon is listed on the AIM Market of the London Stock Exchange. For more information, please visit our www.sopheon.com.

 

# # #

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
NRAFPMRTMBATMTR
Date   Source Headline
21st Feb 20247:00 amRNSCancellation - Sopheon Plc
20th Feb 20244:31 pmRNSScheme of Arrangement becomes Effective
20th Feb 20247:30 amRNSSuspension - Sopheon plc
16th Feb 20241:40 pmRNSIssue of Equity, PDMR Dealing and Rule 2.9
16th Feb 20241:35 pmRNSCourt Sanction of Scheme of Arrangement
16th Feb 20249:04 amRNSForm 8.5 (EPT/NON-RI) - Sopheon PLC
14th Feb 20248:32 amRNSForm 8.5 (EPT/NON-RI)
13th Feb 20245:30 pmRNSSopheon
9th Feb 20243:30 pmRNSForm 8.3 - SPHN LN
9th Feb 20249:35 amRNSForm 8.3 - Sopheon plc
9th Feb 20249:14 amRNSForm 8.5 (EPT/NON-RI)
8th Feb 20242:00 pmRNSResults of Court Meeting and General Meeting
17th Jan 20241:31 pmRNSHolding(s) in Company
17th Jan 20249:42 amRNSForm 8.3 - Sopheon plc
16th Jan 20245:45 pmRNSPublication of Scheme Document
15th Jan 202410:53 amRNSForm 8.3 - Sopheon plc
15th Jan 20248:13 amRNSForm 8.3 - SOPHEON PLC
12th Jan 20243:22 pmRNSForm 8.3 - Sopheon PLC
11th Jan 20248:50 amRNSSatisfaction of NSIA Condition
11th Jan 20248:49 amRNSForm 8.3 - SOPHEON PLC
10th Jan 20249:13 amRNSForm 8.3 - SOPHEON PLC
9th Jan 202412:35 pmRNSForm 8.3 - Sopheon plc
9th Jan 20248:48 amRNSForm 8.3 - SOPHEON PLC
8th Jan 202412:22 pmRNSIssue of Equity
8th Jan 20248:31 amRNSForm 8.3 - SOPHEON PLC
4th Jan 20249:45 amRNSForm 8.3 - SOPHEON PLC
2nd Jan 20245:18 pmRNSForm 8.3 - Sopheon Plc
2nd Jan 20249:07 amRNSForm 8.3 - SOPHEON PLC
22nd Dec 20231:00 pmRNSRecommended Cash Offer
15th Dec 20238:39 amRNSForm 8.5 (EPT/NON-RI)
13th Dec 20238:32 amRNSForm 8.5 (EPT/NON-RI)
12th Dec 202310:55 amRNSForm 8.5 (EPT/NON-RI)
11th Dec 20238:37 amRNSForm 8.5 (EPT/NON-RI)
8th Dec 202310:41 amRNSForm 8.5 (EPT/NON-RI)
6th Dec 20238:36 amRNSForm 8.5 (EPT/NON-RI)
5th Dec 20239:16 amRNSForm 8.5 (EPT/NON-RI)
4th Dec 20236:18 pmRNSRule 2.9 Announcement
4th Dec 202312:30 pmRNSIssue of Equity
28th Nov 20237:00 amRNSOffer update - extension to PUSU Deadline
17th Nov 202311:39 amRNSForm 8.5 (EPT/NON-RI)
15th Nov 20239:30 amRNSForm 8.5 (EPT/NON-RI)
14th Nov 20232:59 pmRNSForm 8.3 - SOPHEON PLC
10th Nov 202311:40 amRNSForm 8.5 (EPT/NON-RI)
10th Nov 202311:09 amRNSForm 8.3 - Rivomore Limited - Sopheon plc - Amend
9th Nov 20239:15 amRNSForm 8.5 (EPT/NON-RI)
8th Nov 202312:57 pmRNSForm 8.3 - Sopheon plc
8th Nov 202310:25 amRNSForm 8.5 (EPT/NON-RI) - Sopheon PLC
8th Nov 20237:00 amRNSForm 8 (OPD) Sopheon plc
7th Nov 202311:24 amRNSForm 8.5 (EPT/NON-RI)
6th Nov 20231:03 pmRNSForm 8.5 (EPT/NON-RI)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.